Demant A/S (WILLF)
OTCMKTS
· Delayed Price · Currency is USD
38.23
+1.98 (5.46%)
May 27, 2025, 4:00 PM EDT
Demant Revenue
In the year 2024, Demant had annual revenue of 22.42B DKK with 3.79% growth. Demant had revenue of 11.33B in the half year ending December 31, 2024, with 11.01% growth.
Revenue
22.42B DKK
Revenue Growth
+3.79%
P/S Ratio
2.66
Revenue / Employee
990.28K DKK
Employees
22,639
Market Cap
8.29B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.42B | 818.00M | 3.79% |
Dec 31, 2023 | 21.60B | 1.90B | 9.62% |
Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |